Search results for "Retinal"

showing 10 items of 631 documents

Indocyanine green in congenital hypertrophy of the retinal pigment epithelium

2005

To report a case of congenital hypertrophy of the retinal pigment epithelium followed up for 7 years showing features not previously reported. A complete fundus examination including fluorescein angiography was performed at first examination and at follow-up. The area of congenital hypertrophy of the retinal pigment epithelium presented morphologic changes, showing enlargement of the lesion on one side associated with partial regression on another side. In addition, the indocyanine green angiography findings revealed that this test was more useful than fluorescein angiography to delineate the real boundaries of the lesion and disclosed hypofluorescent areas inside the main lesion that were …

Indocyanine green Pigment Epithelium of Eye/pathology Retinal Diseases/diagnosis
researchProduct

An SPM-Enriched Marine Oil Supplement Shifted Microglia Polarization toward M2, Ameliorating Retinal Degeneration in rd10 Mice

2022

Retinitis pigmentosa (RP) is the most common inherited retinal dystrophy causing progressive vision loss. It is accompanied by chronic and sustained inflammation, including M1 microglia activation. This study evaluated the effect of an essential fatty acid (EFA) supplement containing specialized pro-resolving mediators (SPMs), on retinal degeneration and microglia activation in rd10 mice, a model of RP, as well as on LPS-stimulated BV2 cells. The EFA supplement was orally administered to mice from postnatal day (P)9 to P18. At P18, the electrical activity of the retina was examined by electroretinography (ERG) and innate behavior in response to light were measured. Retinal degeneration was …

InflammationPhysiologyInherited retinal dystrophiesClinical BiochemistryCell BiologyBiochemistrySpecialized pro-resolving mediatorsMedicaments Assaigs clínicsRetinitis pigmentosainherited retinal dystrophies; retinitis pigmentosa; inflammation; microglia; specialized pro-resolving mediators; oxidative stressOxidative stressUlls Malalties i defectesMicrogliaMolecular Biology
researchProduct

Retinal Fundus Multi-Disease Image Dataset (RFMiD): A Dataset for Multi-Disease Detection Research

2021

The world faces difficulties in terms of eye care, including treatment, quality of prevention, vision rehabilitation services, and scarcity of trained eye care experts. Early detection and diagnosis of ocular pathologies would enable forestall of visual impairment. One challenge that limits the adoption of computer-aided diagnosis tool by ophthalmologists is the number of sight-threatening rare pathologies, such as central retinal artery occlusion or anterior ischemic optic neuropathy, and others are usually ignored. In the past two decades, many publicly available datasets of color fundus images have been collected with a primary focus on diabetic retinopathy, glaucoma, age-related macular…

Information Systems and Managementgenetic structuresVisual impairmentGlaucomaDiseaseFundus (eye)030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinerare pathology detectionmedicineVision rehabilitationmulti-label classificationretinal fundus imagesbusiness.industryocular diseaseDiabetic retinopathyMacular degenerationmedicine.diseaselcsh:Zeye diseaseslcsh:Bibliography. Library science. Information resourcesComputer Science Applicationsclassification030221 ophthalmology & optometryOptometryCentral retinal artery occlusionsense organsmedicine.symptombusinessInformation SystemsData
researchProduct

Visual and optical performance with hybrid multifocal intraocular lenses

2010

During the past years, the wish to become independent of spectacles has been growing among cataract and presbyopic patients due to many factors, such as the increase in near visual demands, the aesthetic need for a spectacle-free image and ageing of refractive surgery patients, among others. This review assesses recently published studies that analyse visual and optical performance through different metrics of eyes implanted with multifocal intraocular lenses (IOLs), particularly hybrid IOL designs. The published evidence suggests that hybrid multifocal IOLs provide very good outcomes in a number of visual and optical performance parameters. Patients implanted with this type of IOL obtain a…

Intraocular LensesOptical PerformanceVisual acuitygenetic structuresCompensation Comparisonmedicine.medical_treatmentKeratomileusis Laser In SituVisual AcuityMethodKeratomileusislaw.inventionGlareLensTratamiento médicoSensitivitylawRefractive surgeryMedicineContrast (vision)MonovisionPostoperative Periodmedia_commonVistaLenses IntraocularMultifocalsGlare (vision)Equipment DesignRefractive ErrorsLens (optics)Bilateral ImplantationApodized Diffractive IolOftalmologíamedicine.symptommedicine.medical_specialtyIn-Situ KeratomileusisRefractivemedia_common.quotation_subjectHigh-Order AberrationsContrast SensitivityOphthalmologyAberrometryClinical-OutcomesHumansRetinal StraylightDepth Perceptionbusiness.industryAberrometryMultifocal intraocular lensContrasteye diseasesOphthalmologyOptometrysense organsbusinessOptometry
researchProduct

2021

Muscarinic acetylcholine receptors (mAChRs) belong to the superfamily of G-protein-coupled receptors (GPCRs). The family of mAChRs is composed of five subtypes, M1, M2, M3, M4 and M5, which have distinct expression patterns and functions. In the eye and its adnexa, mAChRs are widely expressed and exert multiple functions, such as modulation of tear secretion, regulation of pupil size, modulation of intraocular pressure, participation in cell-to-cell signaling and modula-tion of vascular diameter in the retina. Due to this variety of functions, it is reasonable to assume that abnormalities in mAChR signaling may contribute to the development of various ocular diseases. On the other hand, mAC…

Intraocular pressuregenetic structuresGlaucomaCatalysisInorganic Chemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMuscarinic acetylcholine receptormedicineTear secretionPhysical and Theoretical ChemistryReceptorMolecular BiologySpectroscopyG protein-coupled receptorRetinabusiness.industryOrganic ChemistryRetinalGeneral Medicinemedicine.diseaseeye diseasesComputer Science Applicationsmedicine.anatomical_structurechemistry030221 ophthalmology & optometrysense organsbusinessNeuroscience030217 neurology & neurosurgeryInternational Journal of Molecular Sciences
researchProduct

Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat

2012

Purpose: Our previous studies suggested that CYP46A1 and 24S-hydroxycholesterol. (24SOH) may be associated with glaucoma. Loss of CYP46A1-expressing retinal. ganglion cells is involved in the activation of glia, and therefore possibly in the. disbalance of cholesterol. In this context, the purpose of our present work was to. emphasize the glial and longitudinal CYP46A1 expression after an interventional. glaucoma-related stress triggered by elevated intraocular pressure (IOP). Methods: Sprague–Dawley rats were submitted to laser photocoagulation of the. trabecular meshwork, limbus and episcleral veins in one eye to induce elevated IOP. Rats were euthanized at days 3, 14, 30 and 60 (n = 10 p…

Intraocular pressuregenetic structures[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionGlaucomacholesterol homeostasisRats Sprague-Dawleychemistry.chemical_compound0302 clinical medicineHomeostasis0303 health sciencesGeneral MedicineAnatomyGanglionmedicine.anatomical_structureCytokinesIntercellular Signaling Peptides and Proteinsmedicine.symptomNeurogliamedicine.medical_specialtyBlotting WesternContext (language use)BiologyGas Chromatography-Mass SpectrometryRetina03 medical and health sciencesOphthalmologyGlial Fibrillary Acidic ProteinCholesterol 24-HydroxylasemedicineAnimalsIntraocular Pressure030304 developmental biologyRetinaRetinalmedicine.diseaseHydroxycholesterolseye diseasesRatsDisease Models AnimalOphthalmologyglaucomagliosisGliosischemistrySteroid Hydroxylases030221 ophthalmology & optometryOcular HypertensionMuller cellTrabecular meshworksense organs[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Intercurrent factors associated with the development of open-angle glaucoma in The European Glaucoma Prevention Study

2007

Purpose: To evaluate the intercurrent factors for the development of open-angle glaucoma (OAG) in ocular hypertensive patients who were enrolled in the European Glaucoma Prevention Study (EGPS). Design: Randomized, double masked, controlled clinical trial. Methods: setting: Multicenter. study population: A total of 1,077 patients fulfilled a series of inclusion criteria, including intraocular pressure (IOP) 22 to 29 mm Hg, normal and reliable visual fields (VFs) and normal optic disks. intervention: Treatment with dorzolamide or placebo. main outcome measures: Glaucoma-related VF or optic disk changes. Clinical data were collected every six months during a five-year follow-up. Proportional …

Intraocular pressuremedicine.medical_specialtyTime Factorsgenetic structuresOpen angle glaucomaSettore MED/06 - Oncologia MedicaOptic DiskOptic diskOcular hypertensionGlaucomaThiopheneslaw.inventionCorneaDouble-Blind MethodDorzolamideRandomized controlled trialRisk FactorslawOphthalmologyConfidence IntervalsPrevalencemedicineHumansDiureticsglaucoma ocular hypertension intercurrent risk factorsAntihypertensive AgentsIntraocular PressureProportional Hazards ModelsRetrospective StudiesSulfonamidesbusiness.industryHazard ratioRetinal Hemorrhagemedicine.diseaseeye diseasesEuropeOphthalmologyTreatment OutcomeCardiovascular Diseasessense organsbusinessGlaucoma Open-AngleFollow-Up Studiesmedicine.drug
researchProduct

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion

2014

PURPOSE: To evaluate the efficacy and safety of intravitreal aflibercept injections for treatment of macular edema secondary to central retinal vein occlusion (CRVO). DESIGN: A randomized, multicenter, double-masked phase 3 study. PARTICIPANTS: A total of 177 treatment-naive patients with macular edema secondary to CRVO were randomized in a 3:2 ratio. METHODS: Patients received either 2-mg intravitreal aflibercept or sham injections every 4 weeks for 20 weeks. From week 24 to 48, the aflibercept group received aflibercept as needed (pro re nata [PRN]), and the sham group continued receiving sham injections. MAIN OUTCOME MEASURES: The primary efficacy end point was the proportion of patients…

Intraocular pressuremedicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryPhases of clinical researchmedicine.diseaseeye diseases3. Good healthlaw.inventionOphthalmologyCentral retinal vein occlusionRandomized controlled trialPro re natalawOphthalmologymedicinemedicine.symptombusinessMacular edemaAfliberceptmedicine.drugOphthalmology
researchProduct

The Spectrum of Ocular Manifestations in Patients with Waldenström's Macroglobulinemia.

2021

Purpose: To investigate the ocular manifestations in 91 Waldenstrom's macroglobulinemia (WM) patients.Methods: Retrospective, cross-sectional, observational analysis.Results: Ocular impairments, detected in 19 patients, included flame-shaped hemorrhages, venous sausaging, papilledema, macular detachments, or central retinal vein occlusion in 16 patients; paraproteinemic keratopathy in 2; and a CANOMAD syndrome in 1. Best-corrected visual acuity was ≥0.5 logMAR units in 11 of 38 eyes. Intraocular pressure was increased in seven eyes. Genetic analysis in seven patients showed a mutation in the MYD88 gene in six patients and a nonsense mutation in the CXCR4 gene in five patients. Plasmapheresi…

Intraocular pressuremedicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatment03 medical and health sciences0302 clinical medicineCentral retinal vein occlusionOphthalmologymedicineImmunology and AllergyPapilledemabusiness.industryMacroglobulinemiamedicine.diseaseeye diseases3. Good healthOphthalmology030220 oncology & carcinogenesis030221 ophthalmology & optometryRituximabPlasmapheresismedicine.symptombusinessmedicine.drugRetinopathyOcular immunology and inflammation
researchProduct

Kyrieleis’ vasculitis in acute retinal necrosis

2010

We report the first case in the literature of Kyrieleis' vasculitis related to acute retinal necrosis by Varicella zoster virus in a 76-year-old woman with bilateral involvement. In our patient the arterial lesions appeared 15 days after the initial presentation.

Kyrieleis’ vasculitisintegumentary systemherpes virusvirusesShort Reportvirus diseasesretinal necrosisClinical Ophthalmology (Auckland, N.Z.)
researchProduct